Immunitybio, Inc. · NASDAQ:IBRX
Cohen Cheryl sold 131,210 Immunitybio, Inc. shares (Form 4)
Traded Jul 2, 2026 · Filed Jul 6, 2026
On Jul 2, 2026, Cohen Cheryl (Director) sold 131,210 Immunitybio, Inc. shares at US$9.50 for US$1.25M under a trading plan, leaving 125,386 shares. Filed Jul 6, 2026 (Form 4).
- Sold
- 131,210 shares
- Price
- US$9.50
- Value
- US$1.25M
- Holding after
- 125,386 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock | Option exercise | 55,979 | US$2.98 | 256,596 | Direct |
| Jul 2, 2026 | Common Stock | Sale | 131,210 | US$9.50 | 125,386 | Direct |
Source
Related
- Immunitybio, Inc.
- Cohen Cheryl
- Immunitybio, Inc. shareholders
- Form 4 · Cohen Cheryl · Oct 6, 2026
- Form 4 · Simon Barry J. · Oct 6, 2026
- Schedule 13D/A · Cambridge Equities, LP · Aug 6, 2026
- Form 4 · Selecky Christobel · Jul 6, 2026
- Form 4 · Selecky Christobel · Jul 1, 2026
- Form 4 · Simon Barry J. · Jun 26, 2026